Genetics Of Progressive Renal Failure
Kidney International (2005) 67, S36–S40; doi:10.1111/j.1523-1755.2005.09410.x
Prevalence of silent kidney disease in Hong Kong: The Screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program
PHILIP KAM-TAO LI, BONNIE CHING-HA KWAN, CHI BON LEUNG, TZE HOI KWAN, KIM MING WONG, SING LEUNG LUI, WAIKAY TSANG, CHRISTOPHER CHUN YU MAK, SIU KA MAK, ALEXWAI-YIN YU and SYDNEY TANG FOR THE HONG KONG SOCIETY OF NEPHROLOGY
Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong; Tuen Mun Hospital; Queen Elizabeth Hospital; Tung Wah Hospital; Princess Margaret Hospital; Kwong Wah Hospital; Alice Ho Miu Ling Nethersole Hospital; and Queen Mary Hospital, Hong Kong
Correspondence: Dr Philip K.-T. Li, chairman, Hong Kong Society of Nephrology, Chief of Nephrology, Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong. E-mail:philipli@cuhk.edu.hk
Abstract
Prevalence of silent kidney disease in Hong Kong: The Screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.
Background
End-stage renal disease (ESRD) is epidemic worldwide. In Hong Kong, the annual incidence of ESRD has risen from 100 pmp (per million population) in 1996 to 140 pmp in 2003. SHARE (Screening for Hong Kong Asymptomatic Renal Population and Evaluation program) is a population-based screening program aimed at identifying the prevalence of unrecognized renal disease in asymptomatic individuals, allowing further evaluation and disease-modifying interventions.
Methods
From November to December 2003, SHARE was conducted in several large residential communities in Hong Kong. The screening tool included a questionnaire documenting demographics and history or family history of diabetes mellitus (DM), hypertension (HT), and chronic kidney disease (CKD), together with on-site measurements of blood pressure (BP) and urine dipstick for protein, blood, and glucose.
Results
There were a total of 1811 participants. One thousand two hundred and one subjects were entered into the final analysis. Among the 1201 who were apparently "healthy" (asymptomatic and without history of DM, HT, or CKD), the prevalence of positive (
1+) urine dipstick for protein, glucose, blood, protein or blood, any urine abnormality, and HT (BP
140/90) was 3.2%, 1.7%, 13.8%, 16%, 17.4%, and 8.7%, respectively. Thirty three percent of the age over 60 years old group had either hypertension or urine abnormalities, compared with 24.0% in the 41- to 60-year-old group and 9.7% in the 20- to 40-year-old group. Having a family history of diabetes or hypertension increases the risk of having urine abnormalities, while a family history of hypertension also increases the risk of high blood pressure.
Conclusion
It is concluded that subclinical abnormalities in urinalysis or BP readings are prevalent across all age groups in the adult population. An effective screening program at the primary care level that identifies these subjects for further evaluation is warranted, and the public in Hong Kong should be educated toward the significance of such findings in order to have regular health check for asymptomatic renal diseases.
Keywords:
screening, proteinuria, hematuria, glycosuria, hypertension
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Kidney International Original Article
Kidney International Original Article
Risk of developing end-stage renal disease in a cohort of mass screening
Kidney International Original Article


